Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:e66
doi: 10.1161/01.RES.0000219674.81938.63
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lyons, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lyons, M. A.
(Circulation Research. 2006;98:e66.)
© 2006 American Heart Association, Inc.


Letter to the Editor

Arachidonate 5-Lipoxygenase Variants in Atherosclerosis, Obesity, and Bone Traits

Malcolm A. Lyons

Western Australian Institute for Medical Research and Centre for Medical Research, University of Western Australia, Perth, Australia


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

I write regarding publications by Mehrabian et al1,2 appearing in Circulation Research and a subsequent publication by Kuhn et al3 appearing in Arteriosclerosis, Thrombosis, and Vascular Biology. The key implication from the combination of these reports was that amino acid substitutions in arachidonate 5-lipoxygenase (ALOX5) could account for differences in susceptibility to atherosclerosis between mouse strains CAST/EiJ and C57BL/6J. The two putative amino acid substitutions reported by Mehrabian et al to be present in strain CAST/EiJ1 were at positions 645 and 646, which are conserved across human, mouse, rat, dog, cow, and chicken. Indeed, when Kuhn et al3 mutated either or both of these residues in the human cDNA, ALOX5 activity was markedly impaired suggesting a key role for one or both of these residues in protein function. Recently, I determined that the coding sequences reported in the first article and implemented in the third article are incorrect.

We detected QTLs for cholesterol traits on Chr 6 in crosses between strains CAST/EiJ and 129S1/SvImJ4 and between strains CAST/EiJ and DBA/2J5,6 that colocalized with Alox5. The coding region of Alox5 was sequenced among these inbred mouse strains. On comparison of all sequences, we made four observations. (1) Our deduced amino acid sequence derived from strain CAST/EiJ (genomic DNA and cDNA) was different to that reported by Mehrabian et al.1 (2) The amino acid sequence for strain CAST/EiJ was identical to strain C57BL/6J. (3) Residue 645 was identical among all the mouse strains. (4) Strains 129S1/SvImJ and . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Circ. Res.Home page
M. Mehrabian
Response to Arachidonate 5-Lipoxygenase Variants in Atherosclerosis, Obesity, and Bone Traits
Circ. Res., May 12, 2006; 98(9): e68 - e68.
[Full Text] [PDF]